News

Folliculin phosphoproteomics study highlighted in ASBMB Today

  • March 14, 2023
  • Comments off

This news article highlights the study of Iris Glycofrydis published in Molecular and Cellular Proteomics last year. It aimed to uncover the functions of the tumor suppressor Foliculin that plays a role in renal cancer (DOI:10.1016/j.mcpro.2022.100263 ). NB On Nov 22, 2022 she defended her thesis including this study in an excellent manner! See page […]

Read More

19 jan. 2023, Thesis defense Carolien van Alphen “Unpacking the phosphoproteome in AML”

  • January 29, 2023
  • Comments off

Photo impression of a great day that started with a seminar entitled “Phosphoproteomics approaches to rationalise anticancer drug responses: towards next generation precision medicine ” by Prof. Pedro Cutillas of the Barts Cancer Institute in London, followed by the thesis defense ceremony. Carolien did a good job defending her thesis. Together copromotor Jacqueline Cloos and […]

Read More

Position open for mass spectrometrist

  • November 24, 2022
  • Comments off

Biomedical Mass Spectrometry/ Proteomics Expert Academic Transfer: Biomedical Mass Spectrometry/ Proteomics Expert Amsterdam UMC: Vacatures – Biomedical Mass Spectrometry/ Proteomics Expert Position We are looking for an accomplished (Senior) Scientist with ample mass spectrometry expertise, to join the OncoProteomics Laboratory at the Amsterdam University Medical Center. Our focus is on innovative proteomics and data analysis […]

Read More

Souvenir IMSC2022 Clinical Proteomics Course

  • September 20, 2022
  • Comments off

Picture Impression of the short course “Clinical Proteomics” at IMSC2022 in Maastricht. A great thanks to all the course contributors Sander Piersma, Irene Bijnsdorp and Tami Geiger.

Read More

Phosphoproteomics contribution published in Nature revealing that truncated FGFR2 leads to hyperactivity and is a clinically actionable oncogene

  • August 14, 2022
  • Comments off

Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical responses to available therapies remained variable and unpredictable, making it difficult to select patients who would benefit from these types of treatments. An international team of researchers led by Jos Jonkers, group leader at the […]

Read More

CST Webinar Valentina

  • June 10, 2022
  • Comments off

Valentina presents her work in a presentation entitled “Uncovering novel targets for therapy in T-cell acute lymphoblastic leukemia using phosphoproteomics” at a Cell Signaling Webinar on Post Translational Modification next Tuesday June 14th at 15:00.

Read More

Plenary lecture Connie at EuPA2022 in Leipzig

  • June 1, 2022
  • Comments off

It was an honour and great pleasure to speak at the joint German Proteomics Forum -European Proteomics Association meeting in Leipzig on phosphoproteomics for precision medicine. See here for the program full of great science : https://www.proteomic-forum.com/programme/scientific-programme

Read More